Montigen Pharmaceuticals Overview
- Year Founded
-
2003
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Montigen Pharmaceuticals General Information
Description
Operator of drug discovery and development company dedicated to alleviating human suffering by developing novel therapeutics to treat and cure life-threatening diseases. The company utilizes its proprietary revolutionary CLIMB(TM) drug development process to create promising compounds that inhibit aurora-A kinase and small molecules targetting tyrosine-kinase receptors.
Contact Information
Website
www.montigen.comCorporate Office
- 2401 South Foothill Drive
- Salt Lake City, UT 84109
- United States
Corporate Office
- 2401 South Foothill Drive
- Salt Lake City, UT 84109
- United States
Montigen Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Montigen Pharmaceuticals Patents
Montigen Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2007510627-A | Protein kinase inhibitor | Active | 14-Oct-2003 | ||
| US-20090099165-A1 | Protein kinase inhibitors | Inactive | 14-Oct-2003 | ||
| WO-2005037825-A2 | Protein kinase inhibitors | Inactive | 14-Oct-2003 | ||
| WO-2005037825-A3 | Protein kinase inhibitors | Inactive | 14-Oct-2003 | C07D487/04 |
Montigen Pharmaceuticals FAQs
-
When was Montigen Pharmaceuticals founded?
Montigen Pharmaceuticals was founded in 2003.
-
Where is Montigen Pharmaceuticals headquartered?
Montigen Pharmaceuticals is headquartered in Salt Lake City, UT.
-
What industry is Montigen Pharmaceuticals in?
Montigen Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Montigen Pharmaceuticals a private or public company?
Montigen Pharmaceuticals is a Private company.
-
What is the current valuation of Montigen Pharmaceuticals?
The current valuation of Montigen Pharmaceuticals is .
-
What is Montigen Pharmaceuticals’s current revenue?
The current revenue for Montigen Pharmaceuticals is .
-
When was Montigen Pharmaceuticals acquired?
Montigen Pharmaceuticals was acquired on 04-Apr-2006.
-
Who acquired Montigen Pharmaceuticals?
Montigen Pharmaceuticals was acquired by Astex Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process